David N Brindley

18PUBLICATIONS
12CO-AUTHORS
Molecular targetsSolid tumoursTumour immunologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 09, 2025
Inhibition of autotaxin activity with IOA-289 decreases fibrosis in mouse E0771 breast tumors.

Xiaoyun Tang, Humayara Khan, Karolina Niewola-Staszkowska

|Mar 13, 2024
Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for Treatment.

Shirin Bonni, David N Brindley, M Dean Chamberlain

|Jan 26, 2024
Autotaxin and Lysophosphatidate Signaling: Prime Targets for Mitigating Therapy Resistance in Breast Cancer.

Matthew G K Benesch, Xiaoyun Tang, David N Brindley

|Jan 11, 2024
Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs.

Anjali Shinde, Xiaoyun Tang, Rajesh Singh

|Jun 28, 2023
Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression.

Matthew G K Benesch, Rongrong Wu, Xiaoyun Tang

|Jun 10, 2023
Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not.

Xiaoyun Tang, Andrew J Morris, Marcel A Deken

Pageof 3

Frequent Collaborators

4 joint publications

Matthew G K Benesch

3 joint publications

Kazuaki Takabe

2 joint publications

Rongrong Wu

1 joint publications

Maria Eloisa Hasing